The spreading base of the diabetic
patients and augmenting ease in the admittance to type 1 diabetes are likely to
encourage the growth of the market during the review duration. Unadventurous,
Type 1 diabetes patients demanding unvarying glucose observing use needles,
which augments the perils of the infection and pain among the individual.
Needle-free devices deliver the pain less delivery and contradict the peril of
infection. As an effect, the requirement for such devices is estimated to
augment during the review period. Not only has this, the effective increase in
the requirement and technological advancements in the area of pain-free drug
transportation and self-administration have been frolicking an instrumental
role in fueling the market.
Increasing compression to limit the
incidence rate of infectious diseases such as dengue fever, hepatitis,
neurological disorders and AIDS instigated by West Nile virus during the
transmission is expected to portend well for the growth of the market during
the review duration. According to the report analysis, ‘Global Market Insights on Needle-Free Drug Delivery
Systems: Insights and Forecast, 2018-2025: Emphasis on Product (Prefilled
needle-free injection systems, Prefilled needle-free injection systems);
Technology (Jet Injectors, Transdermal Drug Delivery Systems, Inhaler
Technology); Application (Insulin Delivery, Vaccination, Pediatric Injections,
Pain Management); Injection Mode (Powder injections, Liquid injections, Liquid
injections); Source of Power (Spring Loaded Jet Injector, Gas Powered Jet
Injector, Battery Powered Jet Injector) and Region’ states
that in the Global Market Insights on Needle-Free Drug Delivery Systems, there
are several potential corporates which presently functioning more actively for
leading the fastest market growth and registering the handsome value of market
share during the analyzed period more positively while increasing the prevalence
of the Chronic and Lifestyles Diseases, increasing technological advancements
in the devices, growth in the number of start-ups and investments, and
increasing acceptance in the emerging regions of Asia-Pacific economy includes Antares
Pharma, Inc., Consort Medical, Crossject Societe Anonyme, Injex Pharma, Medical International Technology, Zosano
Pharma, Valeritas, 3M, PharmaJet and several others.
In terms of revenue, the needle free
drug delivery device in has accounted an outstanding growth with positive CAGR
during the analyzed period. The needle free drug delivery device market has effectively
observed an overall increase in the needle free penetration as well as needle
free drug delivery devices implementation in last few years. The effective
growth in the number of chronic diseases incidence, inclination towards
self-administration of drugs, increasing technological advancements in the
devices has propelled the growth prospects of the market. In addition, increasing
requirement for the needle free drug delivery device system and rigorous
government regulations undertaken has also substantially catalyzed the growth
potential of the respective market.
Additionally, based on the country, North
America controlled the foremost share due to the high consciousness regarding advantages
of the needle-free drug delivery devices, attendance of developing healthcare
facilities, and R&D expenditure by government. However, the Asia-Pacific
region is estimated to observe the highest growth during the analyzed period.
Therefore, in the near years, it is estimated that the global market insights
on needle-free drug delivery systems will increase around the globe more
positively over the decades.
For
more information on the research report, refer to below link:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
